Velo3D Stock Surges 49% on Margin Expansion and Positive EBITDA Outlook

Velo3D delivered a market-beating performance, with shares surging 49.43% following the release of financial results that exceeded investor expectations and signaled a critical inflection point for the struggling additive manufacturing company. The gains underscore renewed confidence in management's ability to achieve profitability and capitalize on robust demand from the defense and aerospace sectors, which have become increasingly reliant on advanced 3D printing technologies for complex component manufacturing.

Strong Financial Performance Drives Market Confidence

The headline-grabbing numbers tell a compelling story of operational improvement. Velo3D reported gross margins expanding dramatically to 17.2% from just 7.5% in the prior year—a remarkable 960 basis point improvement that signals the company is finally achieving the economies of scale and production efficiency necessary for long-term viability. This margin expansion is particularly significant given the capital-intensive nature of 3D printing manufacturing and the historically thin margins that have plagued the additive manufacturing sector.

Management's forward guidance reinforces the trajectory of improvement:

• Full-year revenue guidance: $60-70 million
• EBITDA inflection point: Expected to turn positive later in 2026
• Gross margin trend: Projected to continue expanding from current 17.2% baseline
• Market focus: Defense and aerospace applications driving near-term growth

The path to positive EBITDA represents a watershed moment for Velo3D, which—like many emerging technology companies—has been burning cash while scaling operations. The company's ability to project EBITDA positivity within a defined timeframe suggests management confidence in both revenue growth and continued operational leverage.

Market Context: Additive Manufacturing at an Inflection Point

The aerospace and defense sectors have become increasingly strategic for 3D printing adoption, driven by several structural factors. Complex geometries that would be impossible or prohibitively expensive to manufacture through traditional subtractive methods can now be produced via additive manufacturing, reducing weight, material waste, and supply chain complexity. This is particularly valuable for aerospace applications where every kilogram matters for fuel efficiency.

Velo3D's outperformance comes amid broader industry dynamics in additive manufacturing. While competitors in the 3D printing space—including Stratasys, 3D Systems, and Materialise—have experienced volatile stock performance, the sector is benefiting from:

• Defense spending increases as geopolitical tensions drive government procurement
• Supply chain resilience initiatives spurring investment in domestic manufacturing
• Sustainability mandates reducing material waste through additive processes
• Aerospace production recovery as commercial aviation normalizes post-pandemic

Velo3D's specific focus on metal additive manufacturing for high-performance applications positions it well within this expanding market, where applications range from jet engine components to missile systems and satellite structures.

Investor Implications: Profitability Within Reach

For investors, the significance of this earnings report extends well beyond a single quarter's performance. The 49.43% stock surge reflects market relief that Velo3D has moved beyond the question of "if" it can achieve profitability and entered the phase of "when." This psychological shift is crucial for capital-constrained technology companies that require sustained investor confidence to access growth capital.

Several factors make this inflection particularly credible:

Gross margin improvement at this magnitude suggests the company has resolved fundamental manufacturing efficiency challenges rather than achieving a temporary cost reduction. Moving from 7.5% to 17.2% gross margins indicates that unit economics have fundamentally shifted in management's favor.

Sector tailwinds provide confidence in revenue guidance. Defense and aerospace spending tends to be less cyclical than broader manufacturing, and both sectors have demonstrated sustained appetite for advanced manufacturing technologies.

Time-defined EBITDA target gives management accountability. Rather than providing vague long-term profitability promises, the company has specified that positive EBITDA should arrive in late 2026, a measurable milestone that investors can track.

For shareholders, the key question becomes whether the company can execute on this roadmap without requiring dilutive capital raises. A company that achieves positive EBITDA while maintaining current share count represents genuine value creation, whereas continued cash burn requiring secondary offerings would erode shareholder returns.

Forward-Looking Assessment

Velo3D's stock surge represents more than short-term enthusiasm; it signals the market's recognition that the company has crossed from the investment phase into the value-creation phase. The combination of expanding gross margins, strong sector-specific demand, and a credible path to profitability creates a narrative that resonates with both growth investors seeking exposure to advanced manufacturing and value investors watching for inflection points in previously struggling companies.

The $60-70 million revenue guidance for the full year, while modest in absolute terms, becomes meaningful when paired with the gross margin story. At the midpoint ($65 million) and 17.2% gross margins, the company is approaching $11 million in gross profit—levels from which EBITDA positivity becomes achievable.

Investors should monitor three critical metrics in coming quarters: whether gross margins sustain at the 17.2% level or continue expanding, whether revenue growth accelerates or merely stabilizes, and whether management's 2026 EBITDA guidance requires revision. For now, Velo3D has provided sufficient evidence that its industrial 3D printing technology addresses genuine market needs with improving unit economics—a combination that historically has rewarded patient investors in capital equipment and manufacturing technology companies.